Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders

Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and α-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD). We screened 83 patients with CMD and other neuromuscular disorders and six controls for mutatio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Peat, Rachel A., Gécz, Jozef, Fallon, Justin R., Tarpey, Patrick S., Smith, Raffaella, Futreal, Andrew, Stratton, Michael R., Lamandé, Shireen R., Yang, Nan, North, Kathryn N.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2873833/
https://ncbi.nlm.nih.gov/pubmed/18602826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nmd.2008.05.013
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares